Business
Australian firm receives FDA approval for ‘breakthrough’ COVID test – Sydney Morning Herald
Brisbane-based diagnostics company Ellume plans to deliver 20 million COVID-19 tests to the US within the first half of 2021.
“By authorising a test for over-the-counter use, the FDA allows it to be sold in places like drug stores, where a patient can buy it, swab their nose, run the test and find out their results in as little as 20 minutes,” Hahn said in a statement.
Lamar Alexander, the chair of the Senate health committee, said: “This is a genuine breakthrough in COVID-19 testing.”
Ellume’s CEO and founder, Sean Parsons, in the company’s east Brisbane lab.
The US is currently testing around 2 million people a day,…
-
General11 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News18 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat
-
Noosa News17 hours agoYork family honours late son with tractor museum to fund cancer research
-
General16 hours agoTeam Australia wins back-to-back Motocross of Nations titles